Navigation Links
Particle Sciences Further Expands Combination Product Development Capabilities
Date:6/16/2009

BETHLEHEM, Pa., June 16 /PRNewswire/ -- Particle Sciences Inc., a leading service provider for the development of thermoplastic based Combination Products (drug-eluting devices), has further expanded their development and pilot production capabilities with the addition of a Leistritz ZSE-18mm twin screw compounding extruder. This expands a compounding, extrusion, pelletization and injection molding line that is suitable for the preparation of high quality Combination Products to support clients' development programs. "With the addition of the Leistritz compounding extruder to our Class 10,000 clean room, Particles Sciences offers development services for thermoplastic Combination Products. We can support such development efforts from concept to clinic," says Dr. Andrew Loxley, Director of New Technologies. Dr. Robert W. Lee, (VP of Pharmaceutical Development) adds, "We are very pleased with the interest we have generated so far. We are now actively working on three Combination Products from different clients, all based on small molecule release from thermoplastics."

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.

    Contact:
    Maureen Cochran
    mcochran@particlesciences.com
    +1-610-861-4701


'/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. UCF researchers nanoparticles could someday lead to end of chemotherapy
2. Novel approach estimates nanoparticles in environment
3. Compact cancer-therapy particle-delivery system patented
4. Nanoparticles May Help Attack Cancer More Directly
5. Stanford researchers harness nanoparticles to track cancer-cell changes
6. Nanoparticle smart bomb targets drug delivery to cancer cells
7. Team Designs Gold Nanoparticles to Deliver Multiple Drugs
8. Gold nanoparticles for controlled drug delivery
9. Nontoxic nanoparticle can deliver and track drugs
10. Nanoparticles trigger cell death?
11. Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona Arizona's ... brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and wellness ... to the store is just one more way Shamangelic Healing supports people’s quest ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... awareness and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics ... 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... infants born with severe congenital diaphragmatic hernia have better survival rates if surgery ... diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent ... Gyrociser, an exercise invention which aids in proper muscle development. , "The Gym ... and Creative Director of World Patent Marketing. "Globalization has threatened the future growth ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... , April 28, 2016   Acsis , a ... that leading IT market research and advisory firm IDC ... the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software ... report provides an assessment of the capabilities and business ... trace software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... Schweiz, April 27, 2016 ... CEO Forums in Zürich gab Strekin AG ... Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens von ... bekannt. Für die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe ... angeworben. STR001 wird während der Operation direkt ...
Breaking Medicine Technology: